The walking capacity assessment in the respiratory patient

Respiration

Volumn 77, Issue 4, 2009, Pages 361-367

  Chetta, Alfredo ^a,b   Pisi, Giovanna ^a   Aiello, Marina ^a   Tzani, Panagiota ^a   Olivieri, Dario ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

6 min walk test; Exercise capacity; Lung disease; Shuttle walking test

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; SALMETEROL;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; DRUG EFFECT; EISENMENGER COMPLEX; EXERCISE TEST; FIBROSING ALVEOLITIS; GAIT; HUMAN; INTERRATER RELIABILITY; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG RESECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; REVIEW; SINGLE DRUG DOSE; WALKING SPEED;

EXERCISE TEST; HUMANS; REPRODUCIBILITY OF RESULTS; RESPIRATION DISORDERS; WALKING;

EID: 67649998911     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000212781     Document Type: Review

References (57)

1. ERS Task Force, Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG, Gosselink R, O'Donnell DE, Puente-Maestu L, Schols AM, Singh S, Whipp BJ: Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29:185-209.
2. Ferrazza D, Martolini G, Valli P: Palange. The cardiopulmonary exercise test in the functional evaluation of the patient with pulmonary diseases. Respiration 2009; 77: 3-17.
3. Clini EM, Crisafulli E: Exercise capacity as a pulmonary rehabilitation outcome. Respiration 20 09; 77: 121-128.
4. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J 1982; 284:1607-1608.
5. Cooper KH: A means of assessing maximal oxygen intake. JAMA 1968; 203:201-204.
6. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al: The six-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Ca n Med Assoc J 1985; 132: 91 9 - 9 2 3.
7. Kotloff RM, Tino G, Palevsky HI, Hansen-Flaschen J, Wahl PM, Kaiser LR, Bavaria JE: Comparison of short-term functional outcomes following unilateral and bilateral lung volume reduction surgery. Chest 1998; 113: 890-895.
8. Chetta A, Aiello M, Foresi A, Marangio E, D'Ippolito R, Castagnaro A, Olivieri D: Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18:170- 175.
9. Chetta A, Pisi G, Zanini A, Foresi A, Grzincich GL, Aiello M, Battistini A, Olivieri D: Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir Med 2001; 95: 986-991.
10. Eng JJ, Chu KS, Dawson AS, Kim CM, Hepburn KE: Functional walk tests in individuals with stroke: relation to perceived exertion and myocardia l exer tion. Stroke 2002; 33: 756-761.
11. Hulens M, Vansant G, Claessens AL, Lysens R, Muls E: Predictors of 6-minute walk test results in lean, obese and morbidly obese women. Scand J Med Sci Sports 2003; 13:98- 105.
12. Esposito JG, Thomas SG, Kingdon L, Ezzat S: Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting. Am J Physiol Endocrinol Metab 2005; 289:E494-E503.
13. Budweiser S, Heidtkamp F, Jörres RA, Heinemann F, Arzt M, Schroll S, Schmidbauer K, Hitzl AP, Pfeifer M: Predictive significance of the six-minute walk distance for long-term survival in chronic hypercapnic respiratory failure. Respiration 2008; 75:418- 426.
14. Solway S, Brooks D, Lacasse Y, Thomas S: A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119 : 256-270.
15. American Thoracic Society Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117.
16. Guyatt GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman L, Jones NL, Fallen EL, Taylor DW: Effect of encouragement on walking test performance. Thorax 1984; 39:818-822.
17. Finley FR, Cody KA: Locomotive characteristics of urban pedestrians. Arch Phys Med Rehabil 1970; 51: 423-426.
18. Falls HB, Humphrey LA: Energy cost of running and walking in young women. Med Sci Sport 1976; 8:9-13.
19. Waters RL, Lunsford BR, Perry J, Byrd R: Energy-speed relationship of walking: standard tables. J Orthop Res 1988; 6:215-222.
20. Enright PL, Sherrill DL: Reference equations for the six-minute walk in healthy adults. A m J Respir Crit Care Med 1998; 158: 1384- 1387.
21. Troosters T, Gosselink R, Decramer M: Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14 : 270.
22. Gibbons WJ, Fruchter N, Sloan S, Levy RD: Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 2001; 21:87- 93.
23. Camarri B, Eastwood PR, Cecins NM, Thompson PJ, Jenkins S: Six minute walk distance in healthy subjects aged 55-75 years. Respir Med 2006; 100:658-665.
24. Chetta A, Zanini A, Pisi G, Aiello M, Tzani P, Neri M, Olivieri D: Reference values for the 6-min walk test in healthy subjects 20-50 years old. Respir Med 2006; 100 : 1573-1578.
25. Kadikar A, Maurer J, Kesten S: The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 1997; 16:313 -319.
26. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR: The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28- 33.
27. Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG: The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996; 110: 325-332.
28. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, Miyatake K: Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161:487-492.
29. Cavagna GA, Margaria R: External work in walking. J Appl Physiol 1963; 18:1-9.
30. 2 in COPD patients. Respir Med 2001; 95: 618-626.
31. Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B: 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003; 123: 1408- 1415.
32. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH: Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.
33. Redelmeier DA, Lorig K: Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. Arch Intern Med 1993; 153:1337-1342.
34. Appleton S, Poole P, Smith B, Veale A, Lasserson TJ, Chan MM: Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 3:CD001104.
35. Casaburi R, Briggs DD Jr, Donohue JF, Serby CW, Menjoge SS, Witek TJ Jr: The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest 2000; 118:1294-1302.
36. O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H: Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23:832-840.
37. Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006:CD003793.
38. Fishman A, Martinez G, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073.
39. Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, Prefaut C: 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 2003; 123: 14 0 1-14 0 7.
40. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP, Martinez FJ: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168:1084-1090.
41. Paciocco G, Martinez FJ, Bossone E, Pielsticker E, Gillespie B, Rubenfire M: Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001; 17:647-652.
42. Villalba WO, Sampaio-Barros PD, Pereira MC, Cerqueira EMFP, Leme CA Jr, Marques-Neto JF, Paschoal IA: Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest 2007; 131:217-222.
43. Chetta A, Castagnetti C, Aiello M, Sergio F, Fabiano N, Tzani P, Marangio E, Olivieri D: Walking capacity and fitness to fly in patients with chronic respiratory disease. Aviat Space Environ Med 20 07; 78: 789-792.
44. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47: 1019 -10 2 4.
45. 2 max. Eur J Appl Physiol Occup Physiol 1982; 49: 1-12.
46. Turner SE, Eastwood PR, Cecins NM, Hillman DR, Jenkins SC: Physiologic responses to incremental and self-paced exercise in COPD. Chest 2004; 126 : 766-773.
47. Arnardóttir RH, Emtner M, Hedenström H, Larsson K, Boman G: Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study. Respir Res 2006; 7:127.
48. Onorati P, Antonucci R, Valli G, Berton E, De Marco F, Serra P, Palange P: Non-invasive evaluation of gas exchange during a shuttle walking test vs a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 2003; 89: 331-336.
49. Win T, Jackson A, Groves AM, Sharples LD, Charman SC, Laroche CM: Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax 2006; 61: 57- 60.
50. Singh SJ, Jones PW, Evans R, Morgan MD: Minimum clinically important improvement for the incremental shuttle walking test. Thorax 2008; 63: 775-777.
51. Verkindre C, Bart F, Aguilaniu B, Fortin F, Guérin JC, Le Merre C, Iacono P, Huchon G: The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease. Respiration 2006; 73: 420-427.
52. Dyer CAE, Singh SJ, Stockley RA, Sinclair AJ, Hill SL: The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax 2002; 57:34-38.
53. Eiser N, Willsher D, Dore CJ: Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients. Respir Med 2003; 97: 407-414.
54. Singh SJ, Morgan MDL, Hardman AE, Rowe C, Bardsley PA: Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 1994;7:2016-2020.
55. Revill SM, Morgan MDL, Singh SJ, Williams J, Hardman AE: The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-222.
56. Pepin V, Brodeur J, Lacasse Y, Milot J, Leblanc P, Whittom F, Maltais F: Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax 2007; 62: 291-298.
57. Brouillard C, Pepin V, Milot J, Lacasse Y, Maltais F: Endurance shuttle walking test: responsiveness to salmeterol in COPD. Eur Respir J 2008; 31:579-584.